Core business
Early Toxicity Prediction and Screening
Early toxicity screening is an essential and indispensable step in the new drug development process. Early termination of compounds that show no development potential can save sponsor substantial amounts of manpower, resources, and time. We offer sponsor comprehensive early toxicity screening services, including early genotoxicity assessment, early general toxicity assessment, and early reproductive and developmental toxicity assessment.
We are equipped with specialized instruments and devices, including flow cytometers, microplate readers, fluorescence microscopes, and PCR machines. These resources enable us to establish animal models for diseases affecting the tumor, cardiovascular, respiratory, metabolic, and urinary systems, and to conduct comprehensive and systematic preclinical studies on drug efficacy and mechanisms at multiple levels.
We offer sponsor comprehensive ADME and pharmacokinetic evaluation and optimization services for entire drug pipelines, supporting their needs from early-stage drug development through to regulatory submissions. Our company has established an animal research platform that complies with AAALAC standards. A professional research team and state-of-the-art instrumentation provide the foundation for delivering high-quality services to our sponsor.
General Toxicological Safety Assessment
The company’s core team boasts extensive experience in toxicology research and has conducted hundreds of drug projects as well as thousands of general toxicology studies on pesticides for its sponsor. Its product portfolio encompasses chemical drugs, biotechnology products, traditional Chinese herbal medicines, and chemicals of various kinds. The team is fully equipped to provide sponsor with sound study designs and appropriate dose selections, ensuring the smooth execution of toxicology studies.
Genotoxicity studies are one of the core modules in drug safety evaluation. We can provide sponsor with assays that comply with ICH-standard combinations, and our study protocol designs meet the requirements of guidelines issued by the FDA, EPA, ICH, OECD, and NMPA.
Developmental and Reproductive Toxicology
Developmental and reproductive toxicology studies are an important component of drug safety evaluation. We can provide sponsor with studies that meet the guidelines set forth by the FDA, EPA, ICH, OECD, and NMPA.
Carcinogenicity studies examine the potential carcinogenic effects of a drug in vivo, thereby evaluating and predicting the possible hazards that the drug may pose to humans. The core members of our team have extensive experience in toxicology research and have been conducting carcinogenicity studies for many years at well-known CRO institutions in China. They have completed nearly a hundred chronic carcinogenicity studies for sponsor and are fully capable of providing high-quality services.
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681